March 24 (Reuters) - T2 Biosystems Inc:
* T2 BIOSYSTEMS ANNOUNCES WORLDWIDE LICENSING AGREEMENT OF COVID-19, NOVEL CORONAVIRUS ASSAY FROM HACKENSACK MERIDIAN HEALTH’S CENTER FOR DISCOVERY AND INNOVATION
* T2 BIOSYSTEMS INC - WILL ADAPT CORONAVIRUS TEST TO RUN ON ITS T2DX INSTRUMENT
* T2 BIOSYSTEMS INC - HACKENSACK MERIDIAN HEALTH WILL ALSO ADOPT T2DX INSTRUMENT AND TEST PANELS Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.